1. Home
  2. TROX vs PRAX Comparison

TROX vs PRAX Comparison

Compare TROX & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROX
  • PRAX
  • Stock Information
  • Founded
  • TROX 2018
  • PRAX 2015
  • Country
  • TROX United States
  • PRAX United States
  • Employees
  • TROX N/A
  • PRAX N/A
  • Industry
  • TROX Major Chemicals
  • PRAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROX Industrials
  • PRAX Health Care
  • Exchange
  • TROX Nasdaq
  • PRAX Nasdaq
  • Market Cap
  • TROX 949.2M
  • PRAX 599.7M
  • IPO Year
  • TROX 2005
  • PRAX 2020
  • Fundamental
  • Price
  • TROX $5.69
  • PRAX $50.36
  • Analyst Decision
  • TROX Buy
  • PRAX Strong Buy
  • Analyst Count
  • TROX 8
  • PRAX 10
  • Target Price
  • TROX $7.56
  • PRAX $101.00
  • AVG Volume (30 Days)
  • TROX 2.6M
  • PRAX 305.1K
  • Earning Date
  • TROX 07-30-2025
  • PRAX 08-12-2025
  • Dividend Yield
  • TROX 8.79%
  • PRAX N/A
  • EPS Growth
  • TROX N/A
  • PRAX N/A
  • EPS
  • TROX N/A
  • PRAX N/A
  • Revenue
  • TROX $3,038,000,000.00
  • PRAX $8,122,000.00
  • Revenue This Year
  • TROX $3.06
  • PRAX N/A
  • Revenue Next Year
  • TROX $4.86
  • PRAX $6,358.50
  • P/E Ratio
  • TROX N/A
  • PRAX N/A
  • Revenue Growth
  • TROX 4.18
  • PRAX 270.02
  • 52 Week Low
  • TROX $4.35
  • PRAX $26.70
  • 52 Week High
  • TROX $17.45
  • PRAX $91.83
  • Technical
  • Relative Strength Index (RSI)
  • TROX 53.16
  • PRAX 71.71
  • Support Level
  • TROX $5.20
  • PRAX $45.70
  • Resistance Level
  • TROX $5.95
  • PRAX $53.35
  • Average True Range (ATR)
  • TROX 0.32
  • PRAX 2.51
  • MACD
  • TROX 0.03
  • PRAX 0.55
  • Stochastic Oscillator
  • TROX 74.76
  • PRAX 76.02

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: